Response to Letter to the Editor From Singhania et al.: "Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades - Yet an Underdiagnosed Disorder"
- PMID: 34734266
- PMCID: PMC8851921
- DOI: 10.1210/clinem/dgab805
Response to Letter to the Editor From Singhania et al.: "Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades - Yet an Underdiagnosed Disorder"
Comment on
-
Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades - Yet An Underdiagnosed Disorder.J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3603-e3610. doi: 10.1210/clinem/dgab327. J Clin Endocrinol Metab. 2021. PMID: 33974052 Free PMC article.
-
Letter to the Editor From Singhania et al: "Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades-Yet an Underdiagnosed Disorder".J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1315-e1316. doi: 10.1210/clinem/dgab804. J Clin Endocrinol Metab. 2022. PMID: 34734261 No abstract available.
References
-
- Singhania P, Bhattacharjee R. Letter to the Editor From Singhania et al.: “Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades – Yet an Underdiagnosed Disorder”. J Clin Endocrinol Metab. Published online before print November 3, 2021;dgab804. doi: 10.1210/clinem/dgab804 - DOI - PubMed
-
- Monticone S, D’Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41-50. - PubMed
-
- Wang K, Hu J, Yang J, et al. Development and validation of criteria for sparing confirmatory tests in diagnosing primary aldosteronism. J Clin Endocrinol Metab. 2020;105(7):e2449-e2456. - PubMed
